个人简历

蔡清清教授现任中山大学肿瘤防治中心内科教授，主任医师，博士生导师，淋巴瘤中心主诊教授，中华医学会肿瘤学分会青年委员会副主委，广东省女医师协会淋巴瘤专业委员会副主委，CSCO淋巴瘤联盟专家委员会委员，广东省抗癌协会血液肿瘤专业委员会秘书、委员，广东省抗癌协会血液肿瘤专业委员会青年委员会副主委，广东省抗癌协会淋巴瘤专业委员会委员，广东省抗癌协会化疗专业委员会委员。2013-2014年在美国M.D.Anderson肿瘤中心进修。研究方向淋巴瘤和头颈癌（鼻咽癌），主持多项国家、地方政府及企事业单位项目，其中2项国家自然科学基金面上项目，1项国家自然科学青年基金项目，已在国际著名期刊发表论文40余篇，其中以第一作者和通讯作者发表20余篇，最高影响因子10.199分。培养及正在培养的博士及硕士研究生9名。获第一批广东省杰出青年医学人才，羊城好医生及广东医院最强科室实力中青年医生称号。

研究领域

擅长恶性淋巴瘤和头颈癌（鼻咽癌等）的诊治及恶性肿瘤的造血干细胞移植治疗。

近期论文

1）Cai Q, Tu M, Xu-Monette ZY, Sun R, Manyam GC, Xu X, Tzankov A, Hsi ED, Møller MB, Medeiros LJ, Ok CY, Young KH. NF-κB p50 activation associated with immune dysregulation confers poorer survival for diffuse large B-cell lymphoma patients with wild-type p53. Mod Pathol. 2017 Mar 10. doi: 10.1038/modpathol.2017.5. [Epub ahead of print] （IF=5.485） 2）Qian D, Chen K, Deng H, Rao H, Huang H, Liao Y, Sun X, Lu S, Yuan Z, Xie D, Cai Q (corresponding author). MicroRNA-374b Suppresses Proliferation and Promotes Apoptosis in T-cell Lymphoblastic Lymphoma by Repressing AKT1 and Wnt-16. Clin Cancer Res. 2015 Jun 22. [Epub ahead of print] （IF=9.6） 3）Chen K, Liu Y, Li W, Chen J, Gu Y, Geng Q, Jiang W, Huang H, Lin T, Xia Z, Cai Q (corresponding author). The prognostic nutritional index predicts survival for patients with extranodal natural killer/T cell lymphoma, nasal type. Ann Hematol. 2015 Aug;94(8):1389-400. （IF=3.083） 4）Cai Q, Luo X, Zhang G, Huang H, Huang H, Lin T, Jiang W, Xia Z, Young KH. New prognostic model for extranodal natural killer/T cell lymphoma, nasal type. Ann Hematol. 2014 Sep;93(9):1541-9. （IF=3.083） 5）Cai Q, Luo X, Liang Y, Rao H, Fang X, Jiang W, Lin T, Lin T, Huang H. Fasting blood glucose is a novel prognostic indicator for extranodal natural killer/T-cell lymphoma, nasal type. British Journal of Cancer. 2013,108(2):380-386（IF=5.569） 6.）Cai Q, Deng H, Xie D, Lin T, Lin T. Phosphorylated AKT Protein Is Overexpressed in Human Peripheral T-cell Lymphomas and Predicts Decreased Patient Survival. Clin Lymphoma Myeloma Leuk. 2012;12(2):106-12. （IF=2.316） 7）Cai Q, Chen K, Chen J, Wu S, Geng Q, Huang H, Lin T, Jiang W, Xia Z, Duan H, Rao H, Yao M, Hu L. The Effect of Prophylactic Lamivudine plus Adefovir Therapy Compared with Lamivudine Alone in Preventing Hepatitis B Reactivation in Lymphoma Patients with High Baseline HBV DNA during Chemotherapy. PLoS One. 2016 Oct 6;11(10):e0164210. doi: 10.1371/journal.pone.0164210. eCollection 2016. （IF=3.057） 8）Cai Q, Hu L, Geng Q, Chen J, Lu Z, Rao H, Liu Q, Jiang W, Huang H, Lin T, Xia Z. New risk factors and new tendency for central nervous system relapse in patients with diffuse large B-cell lymphoma: a retrospective study. Chin J Cancer. 2016 Sep 13;35(1):87. doi: 10.1186/s40880-016-0150-y. （IF=4.111） 9）Cai Q, Medeiros LJ, Xu X, Young KH. MYC-driven aggressive B-cell lymphomas: biology, entity, differential diagnosis and clinical management [Review]. Oncotarget. 2015. （IF=5.008） 10）Chen K, Chen J, Rao H, Guo Y, Huang H, Zhang L, Shao J, Lin T, Jiang W, Zou D, Hu L, Wirian M, Cai Q (corresponding author). Hepatitis B virus reactivation and hepatitis in diffuse large B-cell lymphoma patients with resolved hepatitis B receiving rituximab-containing chemotherapy: riskfactors and survival. Chin J Cancer. 2015 May 28;34(5):225-34. （IF=4.111） 11）Cai Q, Chen Y, Zou D, Zhang L, Badillo M, Zhou S, Lopez E, Jiang W, HuangH, Lin T, Romaguera J, Wang M. Clinical outcomes of a novel combination of lenalidomide and rituximab followed by stem cell transplantation for relapsed/refractory aggressive B-cell non-hodgkin lymphoma. Oncotarget. 2014 Sep 15;5(17):7368-809（IF=5.008） 12）Cai Q, Westin J, Fu K, Desai M, Zhang L, Huang H, Jiang W, Liang R, Qian Z, Champlin RE, Wang M. Accelerated therapeutic progress in diffuse large B cell lymphoma [Review]. Ann Hematol. 2014 Apr;93(4):541-56. （IF=3.083） 13）Cai Q, Huang H, Qian D, Chen K, Luo J, Tian Y, Lin T, LinT. 13-Methyltetradecanoic Acid Exhibits Anti-Tumor Activity on T-Cell Lymphomas In Vitro and In Vivo by Down-Regulating p-AKT and ActivatingCaspase-3.PLoS One. 2013 Jun 7;8(6):e65308.（IF=3.057） 14） Huang H, Cai Q (co-first author) , Lin T, Lin X, Liu Y, Gao Y, Peng R. Lamivudine for the prevention of hepatitis B virus reactivation after high-dose chemotherapy and autologous hematopoietic stem cell transplantation for patients with advanced or relapsed non-Hodgkin's lymphoma single institution experience. Expert Opin Pharmacother. 2009;10(15):2399-406. （IF=3.543） 15） Cai Q, Huang H, Sun X, Xia Z, Li Y, Lin X, Guo Y. Efficacy and safety of transdermal fentanyl for treatment of oral mucositis pain caused by chemotherapy. Expert Opin Pharmacother. 2008;9(18):3137-44. （IF=3.543）